HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition.

AbstractBACKGROUND:
Autophagy is a highly conserved and regulated cellular process employed by living cells to degrade proteins and organelles as a response to metabolic stress. We have previously reported that eukaryotic elongation factor-2 kinase (eEF-2 kinase, also known as Ca(2+)/calmodulin-dependent protein kinase III) can positively modulate autophagy and negatively regulate protein synthesis. The purpose of the current study was to determine the role of the eEF-2 kinase-regulated autophagy in the response of breast cancer cells to inhibitors of growth factor signaling.
METHODOLOGY/PRINCIPAL FINDINGS:
We found that nutrient depletion or growth factor inhibitors activated autophagy in human breast cancer cells, and the increased activity of autophagy was associated with a decrease in cellular ATP and an increase in activities of AMP kinase and eEF-2 kinase. Silencing of eEF-2 kinase relieved the inhibition of protein synthesis, led to a greater reduction of cellular ATP, and blunted autophagic response. We further showed that suppression of eEF-2 kinase-regulated autophagy impeded cell growth in serum/nutrient-deprived cultures and handicapped cell survival, and enhanced the efficacy of the growth factor inhibitors such as trastuzumab, gefitinib, and lapatinib.
CONCLUSION/SIGNIFICANCE:
The results of this study provide new evidence that activation of eEF-2 kinase-mediated autophagy plays a protective role for cancer cells under metabolic stress conditions, and that targeting autophagic survival may represent a novel approach to enhancing the effectiveness of growth factor inhibitors.
AuthorsYan Cheng, Huaijun Li, Xingcong Ren, Tingkuang Niu, William N Hait, Jinming Yang
JournalPloS one (PLoS One) Vol. 5 Issue 3 Pg. e9715 (Mar 16 2010) ISSN: 1932-6203 [Electronic] United States
PMID20300520 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Intercellular Signaling Peptides and Proteins
  • Quinazolines
  • Lapatinib
  • Elongation Factor 2 Kinase
  • Adenylate Kinase
  • Trastuzumab
  • Gefitinib
  • Calcium
Topics
  • Adenylate Kinase (metabolism)
  • Antibodies, Monoclonal (pharmacology)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (pharmacology)
  • Autophagy
  • Breast Neoplasms (metabolism)
  • Calcium (metabolism)
  • Cell Line, Tumor
  • Elongation Factor 2 Kinase (genetics, physiology)
  • Female
  • Gefitinib
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Intercellular Signaling Peptides and Proteins (metabolism)
  • Lapatinib
  • Quinazolines (pharmacology)
  • Signal Transduction
  • Trastuzumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: